GGrantIndex
Sort

146,196 grants matching diabetes

SCH: INT: Collaborative Research: High-throughput Phenotyping on Electronic Health Records using Multi-Tensor Factorization

$692,972
Bradley A Malin · Vanderbilt University Medical Center · · FY2014 · CSE

Strengthening circadian signals to enhance cardiometabolic function

$692,969
Phyllis C Zee · Northwestern University At Chicago · R01 · FY2017 · HL

Adherence & HRQOL: Translation of Interventions

$692,960
Jacqueline M Dunbar-Jacob · University Of Pittsburgh At Pittsburgh · P01 · FY2010 · NR

The metabolic interplay of sleep and Alzheimer's disease

$692,957
Shannon L Macauley-Rambach · University Of Kentucky · R01 · FY2024 · AG

LRRC8 anion channels, superoxide and RhoA in diabetic erectile dysfunction

$692,954
R Clinton Webb · University Of South Carolina At Columbia · R01 · FY2022 · DK

Advancing ADPKD Treatment with GLP-1RA: A Study of Glucagon-Like Peptide-1 Receptor Agonists' Efficacy, Safety, and Mechanism

$692,934
Kristen Lynn Nowak · University Of Colorado Denver · R01 · FY2024 · DK

GWAS for Sleep Apnea and Endothelial Function Among Mexican Americans

$692,891
Craig L Hanis · University Of Texas Hlth Sci Ctr Houston · R01 · FY2011 · HL

Diabetes Prevention Program

$692,890
Trevor J. Orchard · University Of Pittsburgh At Pittsburgh · U01 · FY2011 · DK

Identifying Modifiable Biomarkers/Mediators for Cardiovascular Disease in Chronic Kidney Disease

$692,874
Peter Ganz · University Of California, San Francisco · U01 · FY2017 · DK

Blood Levels of Glycated CD59, a Novel Biomarker to Assess Pregnancy-induced Glucose Intolerance

$692,866
Jose A Halperin · Brigham And Women'S Hospital · R01 · FY2019 · DK

Protein Sequencing by Tandem Mass Spectrometry

$692,862
Donald F Hunt · University Of Virginia · R01 · FY2012 · GM

Evaluation of the entero-insular (incretin) axis in cystic fibrosis-competitive renewal.

$692,825
Andrea Bridget Kelly · Children'S Hosp Of Philadelphia · R01 · FY2020 · DK

Perfluoroalkyl Substances (PFASs) and Liver Cancer Risk in the United States

$692,822
Xuehong Zhang · Yale University · U01 · FY2024 · CA

Deep Phenotyping of Human Knockouts and Population Studies of the APOC3 Pathway

$692,812
Daniel James Rader · University Of Pennsylvania · R01 · FY2019 · HL

Compound Screening in Z-Tag Zebrafish Angiogenesis Assay

$692,782
Peter M. Eimon · Zygogen, Llc · R44 · FY2008 · CA

Mechanisms regulating functional heterogeneity of subcutaneous adipose tissues in women

$692,779
Susan K Fried · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · DK

Mechanisms of Tubular Atrophy

$692,761
Jeffrey R Schelling · Case Western Reserve University · R01 · FY2021 · DK

Role of a Novel Hormone Complex, Fabkin, in Dyslipidemia and Inflammation in Atherosclerosis

$692,742
Gokhan S Hotamisligil · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2025 · HL

Early life glycemic status and Alzheimer's disease neuroimaging markers in middle age: the Bogalusa Heart Study

$692,710
Lydia Bazzano · Tulane University Of Louisiana · R01 · FY2023 · AG

Plasma Sphingolipids and Subclinical and Clinical Cardiovascular Disease

$692,708
Rozenn Lemaitre · University Of Washington · R01 · FY2021 · HL

Enhancing Weight Loss with Financial Incentives in Teens with Severe Obesity

$692,660
Aaron S Kelly · University Of Minnesota · R01 · FY2021 · DK

Enhancing Weight Loss with Financial Incentives in Teens with Severe Obesity

$692,660
Aaron S Kelly · University Of Minnesota · R01 · FY2020 · DK

National estimates of the impact of the affordable care act on healthcare utilization, outcomes and quality among hispanics

$692,648
Amresh D Hanchate · Boston Medical Center · R01 · FY2019 · MD

Searching the blood metabolome to identify risk biomarkers for biliary tract cancer

$692,641
Wei Zheng · Vanderbilt University Medical Center · U01 · FY2022 · CA

Self-Management Interventions in Life-Limiting Illness

$692,629
James Aaron Tulsky · Duke University · P01 · FY2010 · NR